Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
140.80 USD | -0.40% | +2.83% | -4.31% |
Dec. 05 | Intel names two chip industry veterans to its board amid CEO search | RE |
Dec. 05 | Mizuho Adjusts Price Target on Advanced Micro Devices to $180 From $185 | MT |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 6.73B | 9.76B | 16.43B | 23.6B | 22.68B | |||||
Total Revenues | 6.73B | 9.76B | 16.43B | 23.6B | 22.68B | |||||
Cost of Goods Sold, Total | 3.86B | 5.42B | 8.5B | 11.55B | 11.28B | |||||
Gross Profit | 2.87B | 4.35B | 7.93B | 12.05B | 11.4B | |||||
Selling General & Admin Expenses, Total | 750M | 995M | 1.45B | 2.34B | 2.35B | |||||
R&D Expenses | 1.55B | 1.98B | 2.84B | 5B | 5.87B | |||||
Amortization of Goodwill and Intangible Assets - (IS) | - | - | - | 3.55B | 2.81B | |||||
Other Operating Expenses | -60M | - | -12M | -102M | -34M | |||||
Other Operating Expenses, Total | 2.24B | 2.98B | 4.28B | 10.79B | 11B | |||||
Operating Income | 631M | 1.37B | 3.65B | 1.26B | 401M | |||||
Interest Expense, Total | -94M | -47M | -34M | -88M | -106M | |||||
Interest And Investment Income | 15M | 8M | 8M | 65M | 206M | |||||
Net Interest Expenses | -79M | -39M | -26M | -23M | 100M | |||||
Income (Loss) On Equity Invest. | - | 5M | 6M | 14M | 16M | |||||
Currency Exchange Gains (Loss) | -1M | - | - | - | - | |||||
Other Non Operating Income (Expenses) | -3M | -1M | -2M | 5M | -8M | |||||
EBT, Excl. Unusual Items | 548M | 1.33B | 3.63B | 1.26B | 509M | |||||
Restructuring Charges | - | - | - | - | - | |||||
Impairment of Goodwill | - | - | - | - | - | |||||
Gain (Loss) On Sale Of Investments | - | - | 56M | -62M | -1M | |||||
Asset Writedown | - | - | - | - | - | |||||
Other Unusual Items | -176M | -54M | -7M | - | - | |||||
EBT, Incl. Unusual Items | 372M | 1.28B | 3.68B | 1.2B | 508M | |||||
Income Tax Expense | 31M | -1.21B | 513M | -122M | -346M | |||||
Earnings From Continuing Operations | 341M | 2.49B | 3.16B | 1.32B | 854M | |||||
Net Income to Company | 341M | 2.49B | 3.16B | 1.32B | 854M | |||||
Net Income - (IS) | 341M | 2.49B | 3.16B | 1.32B | 854M | |||||
Net Income to Common Incl Extra Items | 341M | 2.49B | 3.16B | 1.32B | 854M | |||||
Net Income to Common Excl. Extra Items | 341M | 2.49B | 3.16B | 1.32B | 854M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 0.31 | 2.1 | 2.61 | 0.85 | 0.53 | |||||
Basic EPS - Continuing Operations | 0.31 | 2.1 | 2.61 | 0.85 | 0.53 | |||||
Basic Weighted Average Shares Outstanding | 1.09B | 1.18B | 1.21B | 1.56B | 1.61B | |||||
Net EPS - Diluted | 0.3 | 2.06 | 2.57 | 0.84 | 0.53 | |||||
Diluted EPS - Continuing Operations | 0.3 | 2.06 | 2.57 | 0.84 | 0.53 | |||||
Diluted Weighted Average Shares Outstanding | 1.12B | 1.21B | 1.23B | 1.57B | 1.62B | |||||
Normalized Basic EPS | 0.31 | 0.7 | 1.87 | 0.5 | 0.2 | |||||
Normalized Diluted EPS | 0.31 | 0.69 | 1.84 | 0.5 | 0.2 | |||||
American Depositary Receipts Ratio (ADR) | 1 | 1 | 1 | 1 | 1 | |||||
Supplemental Items | ||||||||||
EBITDA | 853M | 1.68B | 4.06B | 4.7B | 3.85B | |||||
EBITA | 631M | 1.37B | 3.65B | 4.07B | 3.2B | |||||
EBIT | 631M | 1.37B | 3.65B | 1.26B | 401M | |||||
EBITDAR | 934M | 1.77B | 4.15B | 4.86B | 4.03B | |||||
Effective Tax Rate - (Ratio) | 8.33 | -94.53 | 13.96 | -10.18 | -68.11 | |||||
Current Domestic Taxes | -12M | 5M | 123M | 1.22B | 523M | |||||
Current Foreign Taxes | 50M | 8M | 82M | 161M | 150M | |||||
Total Current Taxes | 38M | 13M | 205M | 1.38B | 673M | |||||
Deferred Domestic Taxes | - | -1.22B | 313M | -1.39B | -889M | |||||
Deferred Foreign Taxes | -7M | -2M | -5M | -114M | -130M | |||||
Total Deferred Taxes | -7M | -1.22B | 308M | -1.5B | -1.02B | |||||
Normalized Net Income | 342M | 834M | 2.27B | 788M | 318M | |||||
Interest on Long-Term Debt | 38M | 10M | - | - | - | |||||
Supplemental Operating Expense Items | ||||||||||
Marketing Expenses | 217M | 314M | 578M | 683M | 695M | |||||
Selling and Marketing Expenses | 217M | 314M | 578M | 683M | 695M | |||||
Research And Development Expense From Footnotes | 1.55B | 1.98B | 2.84B | 5B | 5.87B | |||||
Net Rental Expense, Total | 81M | 86M | 97M | 158M | 173M | |||||
Imputed Operating Lease Interest Expense | 61.59M | 51.45M | 41.78M | 61.5M | 49.13M | |||||
Imputed Operating Lease Depreciation | 19.41M | 34.55M | 55.22M | 96.5M | 124M | |||||
Stock-Based Comp., COGS (Total) | 6M | 6M | 5M | 29M | 30M | |||||
Stock-Based Comp., R&D Exp. (Total) | 129M | 173M | 246M | 697M | 1B | |||||
Stock-Based Comp., SG&A Exp. (Total) | 62M | 95M | 128M | 355M | 352M | |||||
Total Stock-Based Compensation | 197M | 274M | 379M | 1.08B | 1.38B |